A 2025 pilot study infused up to 20 mg of BPC157 intravenously in 2 healthy adults and reported no adverse effects and no abnormal changes in heart, liver, kidney, thyroid, or bloodglucose markers
Cycle structure Cycle Guidelines (community-derived from compound-level data) Approach Pre-blended daily Loading Maintenance 0.52.0 mg total blend daily Total cycle 612 weeks Common context Convenience-first, steady exposure Approach Separate vials standard Loading Weeks 14 Maintenance Weeks 58 Total cycle 812 weeks Common context Loading-then-taper for injury planning Approach Separate vials extended Loading Weeks 14 Maintenance Weeks 512 Total cycle 12 weeks Common context Slower-healing tissue research planning These are research-planning structures, not treatment plans
Stomach problems like nausea and vomiting are also treatable with these injections
The catch: no published, peer-reviewed human randomized controlled trial exists for BPC-157 as of March 2026
A facelift patient will notice that incision line scars heal much flatter and lighter and that the skin within the surgical site improves dramatically during the course of the six-month repair process
Great service fast shipping and quality products Love this product
